Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease
NATURE IMMUNOLOGY, vol.22, no.2, pp.128-151, 2021 (SCI-Expanded)
- Publication Type: Article / Article
- Volume: 22 Issue: 2
- Publication Date: 2021
- Doi Number: 10.1038/s41590-020-00830-z
- Journal Name: NATURE IMMUNOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
- Page Numbers: pp.128-151
- Akdeniz University Affiliated: Yes
Abstract
CHAPLE disease is a lethal syndrome caused by genetic loss of the complement regulatory protein CD55. Lenardo, Ozen and their colleagues report that blockade of C5 complement activation in a small cohort of pediatric patients with CHAPLE disease reduced gastrointestinal pathology and restored their immunity and growth.